Metraipolis › archive › dc_08a0cf186ea2
Engineering mRNA-LNP Medicines for the Ageing Brain: Opportunities and Challenges for Neurodegenerative Diseases — Europe PMC PMID:42713005
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42713005
- DOI
- 10.1002/exp2.70223
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-15T21:58:57.635Z
- SHA-256 of the archived text
f4069bb1c468ea42428d39db11658d071d1dfa4002292a9dd3aaffc1806c377d- Stable URL of this page
https://metraipolis.com/documento/dc_08a0cf186ea2
How to cite
Engineering mRNA-LNP Medicines for the Ageing Brain: Opportunities and Challenges for Neurodegenerative Diseases — Europe PMC PMID:42713005 — Europe PMC (en), https://europepmc.org/article/MED/42713005 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08a0cf186ea2 (Metraipolis archive dc_08a0cf186ea2, sha256 f4069bb1c468ea42428d39db11658d071d1dfa4002292a9dd3aaffc1806c377d)
BibTeX
@misc{dc08a0cf186ea2,
title = {Engineering mRNA-LNP Medicines for the Ageing Brain: Opportunities and Challenges for Neurodegenerative Diseases — Europe PMC PMID:42713005},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42713005},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08a0cf186ea2; sha256 f4069bb1c468ea42428d39db11658d071d1dfa4002292a9dd3aaffc1806c377d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42713005. Agents can read the archived copy with the MCP tool read_document.